Previous Next

2024-03-27

Selective vulnerability to Epstein-Barr virus

Allergology and Immunology

Infection with Epstein-Barr virus may be asymptomatic, cause infectious mononucleosis or cause serious B-cell lymphoproliferative diseases. A selective vulnerability to the virus has been reported in combination with hereditary mutations altering T-cell immunity. In this study, The researchers describe biased variants associated with involvement of the IL-27 pathway, resulting in acute and severe primary EBV infection with a favorable outcome requiring minimal treatment. In in vitro studies, IL-27 exerts a synergistic effect on the proliferation of T lymphocytes dependent on T7 lymphocytes receptors. This proliferation is deficient in some patients, resulting in impaired expansion of cytotoxic CD8+ T lymphocytes, anti-EBV effectors.

Source(s) :
Emmanuel Martin et al. Role of IL-27 in Epstein-Barr virus infection revealed by IL-27RA deficiency. Nature. 2024 Mar 20. ;

Last press reviews


Dengue: Is safe vaccination possible?

#Dengue #Vaccine #Immunity #ADE #Virus #Immunogenicity <br>

One vaccine, two viruses, a thousand hopes

#COVID19 #SARSCoV2 #vaccine<br><br><br>COVID-19,...

West Nile: the fever is rising!

#WestNile #Mosquito #Epidemiology #Zoonosis<br><br><br>West Nile...